Mobile health apps are a valuable source of data that could lead to new clinical and intervention insights, according to Leah Sparks, co-founder and CEO of Wildflower Health. However, she said, users must first overcome their fear of the unknown.
Mobile health apps are a valuable source of data that could lead to new clinical and intervention insights, according to Leah Sparks, co-founder and CEO of Wildflower Health. However, she said, users must first overcome their fear of the unknown.
Transcript (slightly modified)
How has mHealth impacted how patient-specific data is being tracked and analyzed?
Obviously, it makes it so much easier to get that data and to get it real-time, in a scalable way, and get data points that we may not even know are important. So the great thing about sensors, and people tracking things on apps and all these mobile devices, is that we’re getting so much data that before we may not have interactions, or wasn’t possible with other types of technology, and now we’ll get things that may be important that we didn’t even know about. And I think that could be really transformative for both clinical insights and healthcare intervention insights.
What do you think is important for patients and providers to understand about new and engaging technologies like mHealth?
I think that in some parts of the market, some demographics of both patients and physicians, there’s still a lot of fear of the unknown. Fear of security, fear of privacy, and I think those are legitimate. But at the same time, the best way for our healthcare system to evolve is to figure out those challenges and embrace them nonetheless.
So I think there’s just a really important insight that this is the way of the future and we just have to overcome those potential fears on security and privacy. And responsible players in the market, companies like ours and big systems, are addressing those challenges so that we can navigate and really harness that technology for the good of the healthcare system.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More